Welcome to LookChem.com Sign In|Join Free

CAS

  • or

103505-66-4

Post Buying Request

103505-66-4 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

103505-66-4 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 103505-66-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,3,5,0 and 5 respectively; the second part has 2 digits, 6 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 103505-66:
(8*1)+(7*0)+(6*3)+(5*5)+(4*0)+(3*5)+(2*6)+(1*6)=84
84 % 10 = 4
So 103505-66-4 is a valid CAS Registry Number.

103505-66-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name N,N-dibenzyl-nicotinamide

1.2 Other means of identification

Product number -
Other names nicotinic acid dibenzylamide

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:103505-66-4 SDS

103505-66-4Relevant articles and documents

Molecular Determinants of the Platelet Aggregation Inhibitory Activity of Carbamoylpiperidines

Feng, Zixia,Gollamudi, Ramachander,Dillingham, Elwood O.,Bond, Stephen E.,Lyman, Beverly A.,et, al.

, p. 2952 - 2958 (2007/10/02)

A series of α,α'-bis-p-xylenes were synthesized and tested for their inhibitory activity on ADP-induced aggregation of human platelets.A parabolic curve was obtained when log 1/C (activity) was plotted against log P (octanol/water partition coefficient).Using this as a model, a new analogue, α,α'-bis-p-xylene (3g), was synthesized with a predicted IC50 of 25 μM.When this compound was subsequently evaluated, the IC50 was 22.1 +/- 5.5 μM, demonstrating the applicability of this model.The amide oxygen of the carbamoyl substituent appeared necessary for activity.Thus, for example, when the amide carbonyl group of 3a (IC50 = 44.5 μM) was reduced to CH2, the resulting compound 4 had a dramatically reduced activity, IC50 = 1565 μM.Compound 3a was resolved into (+) and (-) enantiomers and a meso (0) diastereomer using fractional crystallization, diastereomeric tartrate formation, and chiral HPLC.Compared to (-)-3a, the (+) isomer was 15 times more potent when ADP was the agonist and 19 times more active when collagen was used as the agonist.Molecullar modeling of R,R and S,S-3a using the SYBYL program was used to examine their interactions with phosphatidylinositol (PI).There was a better fit between PI and the R,R-3a with the energy of interaction being 17.6 kcal/mol less than that of S,S-3a/PI complex.Although the absolute stereochemistry of individual enantiomers is not known, this study shows that R,R-3a interacts more favorably with PI than does S,S-3a and that (+)-3a is a more potent inhibitor of human platelet aggregation than (-)-3a.It is postulated that because of their lipophilicity, these compounds penetrate the platelet membrane and are then protonated at the pH of the cytosol.The protonated N then neutralizes the anionic charge on the membrane phosphoinositides, thereby rendering them less susceptible to hydrolysis by phospholipase C.Thus, the determinant parameters for optimum antiplatelet activity in 3-carbamoylpiperidines are (1) the amide carbonyl, (2) appropriate stereochemistry of the 3-substituent and (3) a log P value of about 4.5.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 103505-66-4